Skip to main content

Advertisement

SpringerLink
Log in

Burden of non-communicable diseases in Iran: past, present, and future

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Iran, as an in-transition country, tackled communicable diseases and now is confronting emerging challenges of non-communicable diseases (NCDs) in the path to reach health for everyone at all ages by 2030. Across Iran, death-averting treatments of NCDs have been expanded recently which might cause a shift toward a greater share of years lived with disability (YLDs) compared to years of life lost (YLLs) in the disability-adjusted life years of NCDs. Since the management of disability differs from the reduction of mortality in terms of public health policies, depicting the current picture of the burden of NCDs is principal for policymakers in achieving health for all. In this communication, we briefly reviewed our current knowledge about the burden of NCDs in Iran and found that burdens of cardiovascular diseases and asthma are shifting toward greater YLDs than YLLs. In addition to expanding preventive measures and maintenance of the current system, this profile calls policymakers for the development of more rehabilitation centers for patients with ischemic heart disease, stroke, and respiratory diseases to mitigate their disabilities. The consistent increase in the age-standardized YLD rate of neoplasms necessitates providing rehabilitation centers as well. Morbidity and mortality of diabetes have increased robustly which warrant extensive preventive and control measures. It should be noted that the estimates of the Global Burden of Disease study offer us invaluable insights on the burden of diseases in Iran; nonetheless, efforts for gathering nationally-representative data, e.g., National and Subnational Burden of Diseases, Injuries, and Risk Factors study, are strongly encouraged in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. UN. Sustainable development goal 3. https://sustainabledevelopment.un.org/sdg3. Accessed Dec 8, 2019.

  2. Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1859–922. https://doi.org/10.1016/S0140-6736(18)32335-3.

    Article  Google Scholar 

  3. Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, et al. Iran in transition. Lancet. 2019;393(10184):1984–2005. https://doi.org/10.1016/S0140-6736(18)33197-0.

    Article  PubMed  Google Scholar 

  4. Kassaian SE, Masoudkabir F, Sezavar H, Mohammadi M, Pourmoghaddas A, Kojuri J, et al. Clinical characteristics, management and 1-year outcomes of patients with acute coronary syndrome in Iran: the Iranian project for assessment of coronary events 2 (IPACE2). BMJ Open. 2015;5(12):e007786. https://doi.org/10.1136/bmjopen-2015-007786.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Poorhosseini H, Abbasi SH. The Tehran Heart Center. Eur Heart J. 2018;39(29):2695–6. https://doi.org/10.1093/eurheartj/ehy369.

    Article  PubMed  Google Scholar 

  6. Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461. https://doi.org/10.1038/s41598-017-13379-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Azizi MH, Bahadori M, Azizi F (2013) History of cancer in Iran. Archives of Iranian medicine. 16(10):613–22. doi:0131610/aim.0015.

  8. WHO. https://www.who.int/features/factfiles/noncommunicable_diseases/en/. Accessed Dec 8, 2019.

  9. Sheidaei A, Gohari K, Kasaeian A, Rezaei N, Mansouri A, Khosravi A et al. (2017) National and Subnational Patterns of Cause of Death in Iran 1990–2015: Applied Methods. Archives of Iranian medicine. 20(1):2–11. doi:0172001/aim.003

  10. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–88. https://doi.org/10.1016/S0140-6736(18)32203-7.

    Article  Google Scholar 

  11. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–858. https://doi.org/10.1016/S0140-6736(18)32279-7.

    Article  Google Scholar 

  12. Sepanlou SG, Parsaeian M, Krohn KJ, Afshin A, Farzadfar F, Roshandel G, et al. Disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE) in Iran and its neighboring countries, 1990-2015: findings from global burden of disease study 2015. Archives of Iranian medicine. 2017;20(7):403–18.

    PubMed  Google Scholar 

  13. Djalalinia S, Saeedi Moghaddam S, Moradi-Lakeh M, Shahraz S, Naghavi M, Murray CJL, et al. Prevalence and years lived with disability of 310 diseases and injuries in Iran and its neighboring countries, 1990-2015: findings from global burden of disease study 2015. Archives of Iranian medicine. 2017;20(7):392–402.

    PubMed  Google Scholar 

  14. Naserbakht M, Djalalinia S, Tayefi B, Gholami M, Eftekhar Ardabili M, Shariat SV et al. (2014) National and sub-national prevalence, trend, and burden of mental disorders and substance abuse in Iran: 1990–2013, study protocol. Archives of Iranian medicine. 17(3):182–8. doi:0141703/aim.008

  15. Farzadfar F, Delavari A, Malekzadeh R, Mesdaghinia A, Jamshidi HR, Sayyari A et al. (2014) NASBOD 2013: design, definitions, and metrics. Archives of Iranian medicine. 17(1):7–15. doi:0141701/aim.004

  16. Mohammadi Y, Parsaeian M, Farzadfar F, Kasaeian A, Mehdipour P, Sheidaei A et al. (2014) Levels and trends of child and adult mortality rates in the Islamic Republic of Iran, 1990–2013; protocol of the NASBOD study. Archives of Iranian medicine. 17(3):176–81. doi:0141703/aim.007

  17. Hassannia T, Farzadfar F, Noori A, Moradi-Lakeh M, Delavari F, Jamshidi HR et al. (2014) National and sub-national prevalence, trend, and burden of end stage renal diseases (ESRD) in Iran 1990–2013; the study protocol. Archives of Iranian medicine. 17(12):800–3. doi:0141712/aim.004

  18. Salimzadeh H, Ardeshir Larijani F, Abedian S, Kalantar Motamedi SM, Malekzadeh MM, Mohaghegh H et al. The trend of national and sub-national burden of gastrointestinal and liver diseases in Iran 1990 to 2013; study protocol. Archives of Iranian medicine. 2014;17(1):33–53. doi:0141701/aim.008.

  19. Shoaee S, Ghasemian A, Najafi B, Kasaeian A, Farzadfar F, Hessari H (2014) National and sub-national burden of oral diseases in Iran: 1990–2013, study protocol. Archives of Iranian medicine. 17(3):159–68. doi:0141703/aim.005

  20. Modirian M, Rahimzadeh S, Cheraghi Z, Khosravi A, Salimzadeh H, Kompani F et al. (2014) Quality evaluation of national cancer registry system in Iran: study protocol. Archives of Iranian medicine. 17(3):193–7. doi:0141703/aim.0010

  21. Niakan Kalhori SR, Tayefi B, Noori A, Mearaji M, Rahimzade S, Zandian E et al. (2014) Inpatient data, inevitable need for policy making at national and sub-national levels: a lesson learned from NASBOD. Archives of Iranian medicine. 17(1):16–21. doi:0141701/aim.005

  22. Moradi-Lakeh M, Sepanlou SG, Karimi SM, Khalili N, Djalalinia S, Karimkhani C, et al. Trend of socio-demographic index and mortality estimates in Iran and its neighbors, 1990-2015; findings of the global burden of diseases 2015 study. Archives of Iranian medicine. 2017;20(7):419–28.

    PubMed  Google Scholar 

  23. Djalalinia S, Saeedi Moghaddam S, Rezaei N, Rezaei N, Mansouri A, Abdolhamidi E, et al. National and sub-national patterns of mortality from stroke in the Iranian population (1990-2015): complementary results from the NASBOD study. International journal of stroke : official journal of the International Stroke Society. 2018;1747493018799974. https://doi.org/10.1177/1747493018799974.

  24. Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30. https://doi.org/10.1016/S0140-6736(16)00618-8.

    Article  Google Scholar 

  25. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. The Lancet. 2016;387(10026):1377–96. doi:https://doi.org/10.1016/S0140-6736(16)30054-X.

  26. Ramezankhani A, Harati H, Bozorgmanesh M, Tohidi M, Khalili D, Azizi F, et al. Diabetes mellitus: findings from 20 years of the Tehran lipid and glucose study. International journal of endocrinology and metabolism. 2018;16(4 Suppl):e84784. https://doi.org/10.5812/ijem.84784.

    Article  PubMed  PubMed Central  Google Scholar 

  27. NCDRC. https://vizit.report/panel/nasbod/en/main.html. Accessed Dec 8, 2019.

  28. Modirian M, Rahimzadeh S, Cheraghi Z, Saeedi Moghaddam S, Rezaei N, Tohidinik HR et al. (2015) Burden of Cancers in Iran from 1990 to 2010: findings from the Global Burden of Disease study 2010. Archives of Iranian medicine. 18(10):629–37. doi:0151810/aim.004

  29. Varmaghani M, Kebriaeezadeh A, Sharifi F, Sheidaei A, Rashidian A, Moradi-Lakeh M, et al. Death-specific rate due to asthma and chronic obstructive pulmonary disease in Iran. Clin Respir J. 2018;12(6):2075–83. https://doi.org/10.1111/crj.12776.

    Article  PubMed  Google Scholar 

  30. Moradi-Lakeh M, Forouzanfar MH, Vollset SE, El Bcheraoui C, Daoud F, Afshin A, et al. Burden of musculoskeletal disorders in the eastern Mediterranean region, 1990-2013: findings from the global burden of disease study 2013. Ann Rheum Dis. 2017;76(8):1365–73. https://doi.org/10.1136/annrheumdis-2016-210146.

    Article  PubMed  Google Scholar 

  31. Sharifi V, Amin-Esmaeili M, Hajebi A, Motevalian A, Radgoodarzi R, Hefazi M et al. (2015) Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011. Archives of Iranian medicine. 18(2):76–84. doi:015182/aim.004

  32. Sharifi F, Fakhrzadeh H, Varmaghani M, Arzaghi SM, Alizadeh Khoei M, Farzadfar F et al. (2016) Prevalence of Dementia and Associated Factors among Older Adults in Iran: National Elderly Health Survey (NEHS). Archives of Iranian medicine. 19(12):838–44. doi:0161912/aim.005

  33. Rezaei N, Asadi-Lari M, Sheidaei A, Khademi S, Gohari K, Delavari F, et al. Liver cirrhosis mortality at national and provincial levels in Iran between 1990 and 2015: a meta regression analysis. PLoS One. 2019;14(1):e0198449. https://doi.org/10.1371/journal.pone.0198449.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Rezaei N, Farzad Far F, Khademiureh S, Sheidaei A, Gohari K, Delavari F, et al. Liver Cancer mortality at national and provincial levels in Iran between 1990 and 2015: a Meta regression analysis. Hepat Mon. 2018;18(1):e62009. https://doi.org/10.5812/hepatmon.62009.

    Article  Google Scholar 

  35. Kelishadi R, Haghdoost AA, Sadeghirad B, Khajehkazemi R (2014) Trend in the prevalence of obesity and overweight among Iranian children and adolescents: a systematic review and meta-analysis. Nutrition (Burbank, Los Angeles County, Calif). 30(4):393–400. doi:https://doi.org/10.1016/j.nut.2013.08.011

  36. Kelly FJ, Fussell JC. Air pollution and airway disease. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2011;41(8):1059–71. https://doi.org/10.1111/j.1365-2222.2011.03776.x.

    Article  CAS  Google Scholar 

  37. Jamaati H, Attarchi M, Hassani S, Farid E, Seyedmehdi SM, Pormehr PS. Investigating air quality status and air pollutant trends over the Metropolitan Area of Tehran, Iran over the past decade between 2005 and 2014. Environ Health Toxicol. 2018;33(2):e2018010-e. https://doi.org/10.5620/eht.e2018010.

    Article  Google Scholar 

  38. Shamsipour M, Hassanvand MS, Gohari K, Yunesian M, Fotouhi A, Naddafi K, et al. National and sub-national exposure to ambient fine particulate matter (PM2.5) and its attributable burden of disease in Iran from 1990 to 2016. Environ Pollut. 2019;255:113173. https://doi.org/10.1016/j.envpol.2019.113173.

    Article  CAS  PubMed  Google Scholar 

  39. Ghasemian A, Rezaei N, Saeedi Moghaddam S, Mansouri A, Parsaeian M, Delavari A et al. (2015) Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990–2010: findings from the Global Burden of Disease Study 2010. Archives of Iranian medicine. 18(8):493–501. doi:015188/aim.006

Download references

Availability of data and material

Not applicable.

Code availability

Not applicable.

Author information

Authors and Affiliations

  1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Second Floor, No.10, Jalal Al-e-Ahmad Highway, Tehran, 1411713137, Iran

    Arya Aminorroaya, Nima Fattahi, Sina Azadnajafabad, Esmaeil Mohammadi, Kosar Jamshidi, Mahtab Rouhifard Khalilabad, Sahar Mohammadi Fateh, Shohreh Naderimagham, Negar Rezaei & Farshad Farzadfar

  2. Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran

    Arya Aminorroaya

  3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

    Mahtab Rouhifard Khalilabad

  4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, No.10, Jalal Al-e-Ahmad Highway, Tehran, 1411713137, Iran

    Shohreh Naderimagham, Negar Rezaei, Bagher Larijani & Farshad Farzadfar

Authors
  1. Arya Aminorroaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nima Fattahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sina Azadnajafabad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Esmaeil Mohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kosar Jamshidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mahtab Rouhifard Khalilabad
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sahar Mohammadi Fateh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shohreh Naderimagham
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Negar Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Farshad Farzadfar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AA prepared the first manuscript. NF, SA, EM, KJ, MR, and SMF helped in the process of literature review and data interpretation. NR, SN, FF, and BL reviewed and commented on the final manuscript. All authors approved the final manuscript. NR and BL were the corresponding authors and supervised all stages of manuscript preparation and publication.

Corresponding authors

Correspondence to Negar Rezaei or Bagher Larijani.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aminorroaya, A., Fattahi, N., Azadnajafabad, S. et al. Burden of non-communicable diseases in Iran: past, present, and future. J Diabetes Metab Disord (2020). https://doi.org/10.1007/s40200-020-00669-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40200-020-00669-z

Keywords

Search

Navigation